Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · IEX Real-Time Price · USD
10.10
-0.07 (-0.69%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Precision BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 57.53 | 48.73 | 25.1 | 115.53 | 24.29 | 22.24 | Upgrade
|
| Revenue Growth (YoY) | 88.25% | 94.15% | -78.28% | 375.72% | 9.20% | 104.34% | Upgrade
|
| Gross Profit | 57.53 | 48.73 | 25.1 | 115.53 | 24.29 | 22.24 | Upgrade
|
| Selling, General & Admin | 38.79 | 41.46 | 43.34 | 43.23 | 39.41 | 30.06 | Upgrade
|
| Research & Development | 53.31 | 51.01 | 44.07 | 111.68 | 94.71 | 79.39 | Upgrade
|
| Operating Expenses | 92.1 | 92.46 | 87.41 | 154.91 | 134.11 | 109.44 | Upgrade
|
| Operating Income | -34.57 | -43.74 | -62.31 | -39.38 | -109.83 | -87.2 | Upgrade
|
| Interest Expense | -2.28 | -2.23 | -1.11 | -0.13 | - | -0.18 | Upgrade
|
| Interest & Investment Income | 7.31 | 7.69 | 3.47 | 0.21 | 0.82 | 4.27 | Upgrade
|
| Earnings From Equity Investments | -1.88 | -4.93 | -1.58 | 0.18 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 10.04 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -21.38 | -43.21 | -61.53 | -39.12 | -109.01 | -83.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.91 | 1.15 | -0.51 | 2.56 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.52 | -0.46 | -0.03 | 5.96 | - | - | Upgrade
|
| Asset Writedown | - | - | -10.84 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -9.76 | Upgrade
|
| Pretax Income | -19.99 | -42.53 | -72.91 | -30.6 | -109.01 | -92.88 | Upgrade
|
| Earnings From Continuing Operations | -19.99 | -42.53 | -72.91 | -30.6 | -109.01 | -92.88 | Upgrade
|
| Earnings From Discontinued Operations | -7.68 | -18.79 | -38.73 | - | - | - | Upgrade
|
| Net Income | -27.67 | -61.32 | -111.64 | -30.6 | -109.01 | -92.88 | Upgrade
|
| Net Income to Common | -27.67 | -61.32 | -111.64 | -30.6 | -109.01 | -92.88 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 24.80% | 31.11% | 49.77% | 12.79% | 23.91% | 166.18% | Upgrade
|
| EPS (Basic) | -6.62 | -15.96 | -38.10 | -15.64 | -62.85 | -66.35 | Upgrade
|
| EPS (Diluted) | -6.62 | -15.96 | -38.10 | -15.64 | -62.85 | -66.35 | Upgrade
|
| Free Cash Flow | -73.15 | -86.07 | -49.07 | -15.91 | -92.42 | -95.68 | Upgrade
|
| Free Cash Flow Per Share | -17.50 | -22.41 | -16.75 | -8.13 | -53.29 | -68.36 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -60.09% | -89.76% | -248.26% | -34.08% | -452.25% | -392.14% | Upgrade
|
| Profit Margin | -48.10% | -125.84% | - | -26.49% | - | - | Upgrade
|
| Free Cash Flow Margin | -127.15% | -176.64% | -195.52% | -13.77% | -380.55% | -430.26% | Upgrade
|
| EBITDA | -28.56 | -36.92 | -54.51 | -30.4 | -101.05 | -81.89 | Upgrade
|
| EBITDA Margin | -49.65% | -75.77% | -217.19% | -26.31% | - | - | Upgrade
|
| D&A For EBITDA | 6.01 | 6.82 | 7.8 | 8.98 | 8.78 | 5.32 | Upgrade
|
| EBIT | -34.57 | -43.74 | -62.31 | -39.38 | -109.83 | -87.2 | Upgrade
|
| EBIT Margin | -60.09% | -89.76% | -248.26% | -34.08% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.